MODEX THERAPEUTIQUES S A has a total of 14 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are GENEMEDICINE CO LTD, CT FOR TRANSLATIONAL RES IN CA and PROVECS MEDICAL GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | United States | 3 | |
#4 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Thorens Bernard | 7 |
#2 | Baetge E Edward | 6 |
#3 | Wong Shou | 5 |
#4 | Dupraz Philippe | 4 |
#5 | Pralong William | 2 |
#6 | Baetge Edward E | 2 |
#7 | Peduto Giovanni | 2 |
#8 | Schneider Bernard-Laurent | 2 |
#9 | Borkenhagen Markus | 2 |
#10 | Aebischer Patrick | 2 |
Publication | Filing date | Title |
---|---|---|
US6673603B2 | Cell paste comprising keratinocytes and fibroblasts | |
US6451601B1 | Transiently immortalized cells for use in gene therapy | |
AU2930601A | Methods of increasing the glucose responsiveness of pancreatic beta-cells | |
US6358739B1 | Transiently immortalized cells | |
WO0054786A1 | Methods and compositions for tolerizing hosts for long term survival of tissue transplants | |
AU3623199A | Flat sheet cell encapsulation device | |
AU3047299A | Methods of delivering glp-1 |